Simultaneous measurement of 13 circulating vitamin D3 and D2 mono and dihydroxy metabolites using liquid chromatography mass spectrometry.


Journal

Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306

Informations de publication

Date de publication:
27 09 2021
Historique:
received: 14 04 2021
accepted: 07 05 2021
pubmed: 21 5 2021
medline: 15 3 2022
entrez: 20 5 2021
Statut: epublish

Résumé

Clinical evaluation of vitamin D status is conventionally performed by measuring serum levels of a single vitamin D metabolite, 25-hydroxyvitamin D predominantly by immunoassay methodology. However, this neglects the complex metabolic pathways involved in vitamin D bioactivity, including two canonical forms D3 and D2, bioactive 1,25-dihydroxy metabolites and inactive 24-hydroxy and other metabolites. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can measure multiple analytes in a sample during a single run with high sensitivity and reference level specificity. We therefore aimed to develop and validate a LC-MS/MS method to measure simultaneously 13 circulating vitamin D metabolites and apply it to 103 human serum samples. The LC-MS/MS method using a Cookson-type derivatization reagent phenyl-1,2,4-triazoline-3,5-dione (PTAD) quantifies 13 vitamin D metabolites, including mono and dihydroxy-metabolites, as well as CYP11A1-derived D3 and D2 metabolites in a single run. The lower limit of quantitation was 12.5 pg/mL for 1,25(OH) This profiling method can provide new insight into circulating vitamin D metabolite pathways forming the basis for improved understanding of the role of vitamin D in health and disease.

Identifiants

pubmed: 34013677
pii: cclm-2021-0441
doi: 10.1515/cclm-2021-0441
pmc: PMC8419114
mid: NIHMS1712261
doi:

Substances chimiques

Vitamins 0
Vitamin D 1406-16-2
Cholecalciferol 1C6V77QF41
Calcifediol P6YZ13C99Q

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1642-1652

Subventions

Organisme : BLRD VA
ID : I01 BX004293
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR071189
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073004
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI149267
Pays : United States

Informations de copyright

© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Références

J Steroid Biochem Mol Biol. 2020 Mar;197:105519
pubmed: 31715316
J Clin Endocrinol Metab. 2014 Jul;99(7):2567-74
pubmed: 24670084
Genes Immun. 2020 May;21(3):150-168
pubmed: 32203088
J Steroid Biochem Mol Biol. 2015 May;149:153-65
pubmed: 25727742
Int J Anal Chem. 2016;2016:8501435
pubmed: 27127512
J Steroid Biochem Mol Biol. 2008 Dec;112(4-5):213-9
pubmed: 19000766
J Steroid Biochem Mol Biol. 2011 Sep;126(3-5):72-7
pubmed: 21605672
Anal Chem. 2003 Jul 1;75(13):3019-30
pubmed: 12964746
Clin Chem. 2016 Jan;62(1):236-42
pubmed: 26585929
Calcif Tissue Int. 2013 Feb;92(2):118-27
pubmed: 23314742
Drug Metab Dispos. 2011 Sep;39(9):1577-88
pubmed: 21677063
Biochemistry. 1989 Feb 21;28(4):1763-9
pubmed: 2719932
Clin Chem Lab Med. 2020 Jan 28;58(2):197-201
pubmed: 31804956
Kidney Int. 2012 Sep;82(6):693-700
pubmed: 22648296
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Nov 20;1158:122394
pubmed: 33091679
Sci Rep. 2015 Oct 08;5:14875
pubmed: 26445902
Clin Chem. 2015 Aug;61(8):1033-48
pubmed: 26130585
J Med Chem. 2015 Oct 8;58(19):7881-7
pubmed: 26367019
Int J Med Sci. 2017 Sep 4;14(11):1080-1087
pubmed: 29104461
J Clin Endocrinol Metab. 2014 Mar;99(3):808-16
pubmed: 24423328
FASEB J. 2012 Sep;26(9):3901-15
pubmed: 22683847
Arch Pathol Lab Med. 2019 Dec;143(12):1531-1538
pubmed: 31116045
J Clin Endocrinol Metab. 2013 Mar;98(3):995-1005
pubmed: 23386642
J Steroid Biochem Mol Biol. 2017 Oct;173:42-56
pubmed: 27693422
Drug Metab Dispos. 2013 May;41(5):1112-24
pubmed: 23454830
Ann Epidemiol. 2009 Feb;19(2):73-8
pubmed: 18329892
J Clin Endocrinol Metab. 2013 Feb;98(2):E298-303
pubmed: 23295467
Clin Chem. 2003 Jul;49(7):1041-4
pubmed: 12816898
Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):734-40
pubmed: 24100666
Anal Chem. 2010 Mar 15;82(6):2488-97
pubmed: 20151683
J Steroid Biochem Mol Biol. 2015 Jul;151:25-37
pubmed: 25448732
Int J Biochem Cell Biol. 2012 Nov;44(11):2003-18
pubmed: 22877869
J Steroid Biochem Mol Biol. 2019 Feb;186:4-21
pubmed: 30205156
Oncotarget. 2017 Feb 7;8(6):9823-9834
pubmed: 28039464
Clin Chem. 2011 Nov;57(11):1618-9
pubmed: 21914787
Br J Nutr. 2010 Aug;104(4):612-9
pubmed: 20712915
J AOAC Int. 2017 Sep 1;100(5):1277-1287
pubmed: 28847346
Lancet Diabetes Endocrinol. 2021 Jan;9(1):32-45
pubmed: 33338415
Anal Bioanal Chem. 2008 May;391(1):229-38
pubmed: 18087693
J Steroid Biochem Mol Biol. 2019 Apr;188:23-28
pubmed: 30553931
Mol Cell Endocrinol. 2014 Mar 5;383(1-2):181-92
pubmed: 24382416
J Nutr Biochem. 2017 Aug;46:21-29
pubmed: 28437713
Calcif Tissue Int. 2020 Jan;106(1):3-13
pubmed: 31741016
J Steroid Biochem Mol Biol. 2017 Oct;173:341-348
pubmed: 28193495

Auteurs

Carl Jenkinson (C)

Andrology, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia.
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Reena Desai (R)

Andrology, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia.

Andrzej T Slominski (AT)

Department of Dermatology, University of Alabama at Birmingham, Pathology and Laboratory Medicine Service, VA Medical Center, Birmingham, AL, USA.

Robert C Tuckey (RC)

School of Molecular Sciences, The University of Western Australia, Perth, WA, Australia.

Martin Hewison (M)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

David J Handelsman (DJ)

Andrology, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH